Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II1 Apr 2016MP66-02 DOWN-REGULATION OF CDKN3 INHIBITED PROSTATE CANCER PROLIFERATION IN VITRO AND IN VIVO VIA REGULATING CELL CYCLE AND DNA REPLICATION SIGNALING yiping zhu, dingwei ye, and bo dai yiping zhuyiping zhu More articles by this author , dingwei yedingwei ye More articles by this author , and bo daibo dai More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.1276AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Cyclin-dependent kinase inhibitor 3 (CDKN3) is aberrantly expressed in several human cancers and plays an important role in regulating cell division. However, the functional role of CDKN3 in prostate cancer (PCa) remains to be elucidated. In this study, we explored its functional role and the molecular mechanisms in human PCa cell lines. METHODS We first assayed the expression of CDKN3 in PCa tissue samples and PCa cell lines by real-time PCR and western blotting. We then defined the biological functions of CDKN3 by CCK-8 assay, flow cytometry and transwell assay. We used Gene set enrichment analysis (GSEA) of KEGG dataset to probe the CDKN3-associated pathways and confirmed the findings from GSEA by Western blotting. Nude mouse xenograft experiment was performed to assay the effect of CDKN3 down-regulation on tumor growth. RESULTS CDKN3 expression was markedly increased in prostate cancer tissues and prostate cancer cell lines LNcap and PC3(Figure 1). Moreover, down-regulation of CDKN3 inhibited cell proliferation, induced a G1 phase arrest in cell cycle, inhibited cell invasion and promoted cell apoptosis in LNcap and PC3 cells. GSEA showed that cell cycle and DNA replication signaling were correlatively with CDKN3 expression. Western blot results showed that the expression levels of cell cycle related proteins PCNA and CDK1 were down-regulated and DNA replication related proteins MCM2 and MCM3 were also reduced (Figure 2). Finally, in vivo data showed that knockdown of CDKN3 expression dramatically inhibited the prostate tumor growth in nude mouse (Figure 3). CONCLUSIONS Our data suggest an important role of CDKN3 in the molecular etiology of prostate cancer and implicate the potential application of CDKN3 in prostate cancer therapy. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e873 Advertisement Copyright & Permissions© 2016MetricsAuthor Information yiping zhu More articles by this author dingwei ye More articles by this author bo dai More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Cyclin-dependent Kinase Inhibitor 3 (CDKN3) Plays a Critical Role in Prostate Cancer Via Regulating Cell Cycle and DNA Replication Signaling

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

MP66-02 DOWN-REGULATION OF CDKN3 INHIBITED PROSTATE CANCER PROLIFERATION IN VITRO AND IN VIVO VIA REGULATING CELL CYCLE AND DNA REPLICATION SIGNALING

Suppression of CDCA3 Inhibits Prostate Cancer Progression Via NF‑κB/cyclin D1 Signaling Inactivation and P21 Accumulation.

CRABP2 Promotes Cell Migration and Invasion by Activating PI3K/AKT and MAPK Signalling Pathways Via Upregulating LAMB3 in Prostate Cancer

The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma

Polo-like Kinase 3 is Associated with Poor Prognosis and Regulates Proliferation and Metastasis in Prostate Cancer

DOK3 promotes proliferation and inhibits apoptosis of prostate cancer via the NF-κB signaling pathway

LncRNA KCNK15-AS1 inhibits pancreatic cancer progression by promoting the expression of its binding protein ACTR3B

Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis

Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells

CDCA3 Mediates P21-Dependent Proliferation by Regulating E2F1 Expression in Colorectal Cancer

The cell cycle gene centromere protein K (CENPK) contributes to the malignant progression and prognosis of prostate cancer

A critical role of CDKN 3 in gastric cancer and regulates tumor cell proliferation

CDCA5 Promotes the Progression of Prostate Cancer by Affecting the ERK Signalling Pathway.

Cyclin-Dependent Kinase Inhibitor 3 is Overexpressed in Hepatocellular Carcinoma and Promotes Tumor Cell Proliferation

Effect of the Circcdr1as/mir-641/Xiap Regulatory Axis on the Proliferation and Invasion of the Prostate Cancer PC-3 Cell Line

The Prognostic Significance of EIF3C Gene during the Tumorigenesis of Prostate Cancer.

Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer

MicroRNA-194 Regulates Cell Viability and Apoptosis by Targeting CDH2 in Prostatic Cancer

Cell Division Cycle-Associated Protein 3 (CDCA3) is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer